期刊文献+

外周血血小板与淋巴细胞绝对值比值在甲状腺髓样癌中的价值

Value of Platelet-to-Lymphocyte Ratio in Peripheral Blood in Medullary Thyroid Carcinoma
下载PDF
导出
摘要 目的通过比较甲状腺髓样癌(MTC)患者和健康人群外周血中血小板与淋巴细胞绝对值比值(PLR)水平,探讨PLR在MTC中的价值。方法选取2007年1月至2019年8月南昌大学第一附属医院收治的经病理证实的30例MTC患者(MTC组)与30例健康体检者(对照组)为研究对象,均行血常规检测,比较2组外周血PLR水平。结果MTC组PLR水平为(135.85±41.94),对照组为(113.41±30.67),MTC组PLR水平明显高于对照组,差异有统计学意义(P=0.02)。结论甲状腺髓样癌患者外周血PLR水平升高,提示体内存在炎症微环境紊乱,这可能在MTC的诊断中有提示价值。 Objective To investigate the value of platelet-to-lymphocyte ratio(PLR)in medullary thyroid carcinoma(MTC)through comparing the PLR in peripheral blood between MTC patients and healthy population.Methods Thirty patients admitted to the First Affiliated Hospital of Nanchang University from January 2007 to August 2019 for pathologically confirmed MTC(MTC group)and 30 healthy subjects(control group)were selected in this study.Routine blood test was performed to detect the PLR in peripheral blood.Results The PLR in MTC group(135.85±41.94)was significantly higher than that in control group(113.41±30.67)(P=0.02).Conclusion Peripheral blood PLR increases in MTC patients,indicating the presence of inflammatory microenvironment disorder in the body.Therefore,PLR is of value in the diagnosis of MTC.
作者 江阳珍 汤佳珍 JIANG Yang-zhen;TANG Jia-zhen(Department of Endocrinology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,China)
出处 《实用临床医学(江西)》 CAS 2020年第8期4-5,44,共3页 Practical Clinical Medicine
基金 江西省教育厅科学技术研究项目(150256)。
关键词 甲状腺髓样癌 外周血 血小板与淋巴细胞绝对值比值 炎症反应 medullary thyroid carcinoma peripheral blood platelet-to-lymphocyte ratio inflammatory response
  • 相关文献

参考文献7

二级参考文献74

  • 1成东华.甲状腺癌的TNM分期[J].中国实用外科杂志,2004,24(10):636-636. 被引量:15
  • 2孔丽慧,吴艳萍.恶性肿瘤继发性血小板增多症四例[J].肿瘤研究与临床,2006,18(7):484-485. 被引量:3
  • 3伍治平,王熙才,金从国,陈晓群,蒋永新,谷玉兰,陈艳.结直肠癌患者外周血血小板活化标志物检测及临床意义[J].中华肿瘤防治杂志,2006,13(13):1008-1010. 被引量:14
  • 4储以微,温锦娣,熊思东.淋巴细胞减少状态下的肿瘤免疫格局改变及其意义[J].中国肿瘤生物治疗杂志,2007,14(1):7-13. 被引量:9
  • 5Ikeda M, Frukawa H, Imamura H, et al. Poor prognosis asso- ciated with thromoocytosis in patients with gastric cancer [ J ]. Ann Surg Oncol, 2002,9 ( 3 ) : 287 - 291.
  • 6Losada R, Espinosa E. Thrombocytosis in patients with acute promyeloeytie leukaemia during all - trans retinoic acid treatment [ J ]. Br J Haematol, 1996,95 (4) :704 - 705.
  • 7Kato N, Yasukawa K, Onozuka T, et al. Paraneoplastic syn- dromes of leukocytosis, thrombocytosis, and hypercalcemiaassociated with squamous cell carcinoma [ J ]. J Dermatol, 1999,26(6) :352 - 358.
  • 8Tomita M, Shimizu T, Hara M, et al. Prognostic impact of thrombocytosis in resectable nonsmall cell lung cancer [ J ]. Interact Car diovasc Thorac Surg, 2008,7 (4) : 613 - 615.
  • 9Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy asso- ciated thrombosis [ J ]. Blood, 2008, 111 ( 10 ) : 4902 - 4907.
  • 10Ko Y J, Small E J, Kabbinavar F, et al. Amuhi - institutional phase ii study of SU 101 : a platelet - derived growth factor receptor inhibitor, for patients with hormone - refractory prostae cancer [ J ]. Clin Cancer Res, 2001,7 (4) : 800 - 805.

共引文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部